We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Abbott to Acquire Alere for $5B

News   Feb 01, 2016

 
Abbott to Acquire Alere for $5B
 
 
Advertisement
 

RELATED ARTICLES

Human Cell “Membrane-on-Chip'” Helps Hunt for Drugs Against COVID-19

News

Researchers have created a human cell '"membrane on a chip" that allows continuous monitoring of how drugs and infectious agents interact with our cells. The device could soon be used to screen potential drug candidates against SARS-CoV-2.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

Oropharyngeal Secretions May Help To Reduce False Negative COVID-19 Test Results

News

A new study published in the Journal of Dental Research demonstrates that testing of oropharyngeal secretions may reduce the number of false negative results from nasal swab testing of COVID-19 patients.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE